Inflammatory bowel disease and pregnancy;Maladies inflammatoires de l'intestin et procréation

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 6-7, 2003, Pages 618-626

  Couve, Sophie ^a   Seksik, Philippe ^a   Elefant, Elisabeth ^b   Jian, Raymond ^a   Marteau, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE; PREDNISONE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; STEROID; THALIDOMIDE;

ABORTION; ARTHROPATHY; ARTIFICIAL FEEDING; BREAST FEEDING; CARCINOGENICITY; CONCEPTION; CONGENITAL MALFORMATION; CONSTIPATION; CONTRACEPTION; CROHN DISEASE; DELIVERY; DIARRHEA; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG SAFETY; ENTERITIS; FEMALE FERTILITY; FETUS DEATH; FETUS MORTALITY; FETUS WASTAGE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPOTROPHY; ILEOANAL ANASTOMOSIS; IMMUNE DEFICIENCY; INTRAUTERINE CONTRACEPTIVE DEVICE; MUTAGENICITY; NONHUMAN; ORAL CONTRACEPTION; PREGNANCY; PREMATURITY; PUERPERIUM; RADIOGRAPHY; REVIEW; RISK FACTOR; SIDE EFFECT; TERATOGENICITY;

ABNORMALITIES; ABORTION, SPONTANEOUS; BREAST FEEDING; DELIVERY, OBSTETRIC; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 0038165028     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Olsen KO, Joelsson M, Laurberg S, Oresland T. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 1999;86:493-5.
2. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997;58:229-37.
3. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998;27:213-24.
4. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-94.
5. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986;27:821-5.
6. Arkuran C, McComb P. Crohn's disease and tubal infertility: the effect of adhesion formation. Clin Exp Obstet Gynecol 2000;27:12-3.
7. Ording OK, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002;122:15-9.
8. Tiainen J, Matikainen M, Hiltunen KM. Ileal J-pouch - anal anastomosis, sexual dysfunction, and fertility. Scand J Gastroenterol 1999;34:185-8.
9. Olsen KO, Juul S, Bülow S, Järvinen HJ, Bakka A, Björk J, et al. Female fecondity before and after surgery for familial adenomatous polyposis (FAP). Ann Surg (in press).
10. Ravid A, Richard C, O'Connor BI, Spencer LM, Kennedy ED, Mukraj D, et al. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis (abstract). Gastroenterology 2001;120(suppl 1):2417.
11. Wikland M, Jansson I, Asztely M, Palselius I, Svaninger G, Magnusson O, et al. Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Colorectal Dis 1990;5:49-52.
12. Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993;54:256-60.
13. Zerner J, Miller BA, Festino MJ. Failure of an intrauterine device concurrent with administration of corticosteroids. Fertil Steril 1976;27:1467-8.
14. Papiernik E, Rozenbaum H, Amblard P, Dephot N, de Mouzon J. Intra-uterine device failure: relation with drug use. Eur J Obstet Gynecol Reprod Biol 1989;32:205-12.
15. Zelissen PM, van Hattum J, Poen H, Scholten P, Gerritse R, te Velde ER. Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroenterol 1988;23:1100-4.
16. Hanker JP. Gastrointestinal disease and oral contraception. Am J Obstet Gynecol 1990;163:2204-7.
17. Nilsson LO, Victor A, Kral JG, Johansson ED, Kock NG. Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy. Contraception 1985;31:195-204.
18. Orholm M, Fonager K, Sorensen HT. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol 1999;94:3236-8.
19. Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998;16:351-5.
20. Akolkar PN, Gulwani-Akolkar B, Heresbach D, Lin XY, Fisher S, Katz S, et al. Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease. Am J Gastroenterol 1997;92:2241-4.
21. Bennett RA, Rubin PH, Present DH. Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 1991;100:1638-43.
22. Laharie D, Debeugny S, Peeters M, Van Gossum A, Gower-Rousseau C, Belaiche J, et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001;120:816-9.
23. Hugot JP. Rôle du gène NOD2 dans la maladie de Crohn. Gastroenterol Clin Biol 2002;26:13-5.
24. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
25. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981;80:72-6.
26. Tennenbaum R, Marteau P, Eléfant E, Rambaud JC, Modigliani R, Gendre JP, et al. Pronostic de la grossesse au cours des maladies inflammatoires intestinales. Gastroenterol Clin Biol 1999;23:464-9.
27. Cléandre D, Dufour P, Tiberghien B, Bernardi C, Vinatier D, Monnier JC. Entérocolites chroniques idiopathiques et grossesse. Répercussions mutuelles et traitements. J Gynecol Obstet Biol Reprod (Paris) 1993;22:59-65.
28. Norgard B, Fonager K, Pedersen L, Jacobsen BA, Sorensen HT. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003;52:243-7.
29. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - a population-based cohort study. Am J Obstet Gynecol 1997;177:942-6.
30. Rogers RG, Katz VL. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol 1995;12:262-4.
31. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998;93:2426-30.
32. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol 2000;95:1021-6.
33. Larzillière I, Beau P. Maladies inflammatoires chroniques intestinales et grossesse. Gastroenterol Clin Biol 1998;22:1056-60.
34. Roux C, Migne G, Mulliez N, Youssef S. Fréquence des malformations à la naissance. Etude d'une maternité parisienne pendant 5 ans. J Gynecol Obstet Biol Reprod (Paris) 1982;11:215-26.
35. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 1984;25:52-6.
36. Marteau P, Tennenbaum R, Eléfant E, Lemann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 1998;12:1101-8.
37. Agret F. Etude de l'effet de la grossesse sur l'évolution de la maladie de Crohn pendant la période gestationnelle et le post partum. Thèse de Doctorat de Médecine. Université Paris VI, Faculté de Médecine Saint Antoine.
38. Nwokolo CU, Tan WC, Andrews HA, Allan RN. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut 1994;35:220-3.
39. Castiglione F, Pignata S, Morace F, Sarubbi A, Baratta MA, D'Agostino L, et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996;28:199-204.
40. Buyon JP. The effects of pregnancy on autoimmune diseases. J Leukoc Biol 1998;63:281-7.
41. Toppenberg KS, Hill DA, Miller DP. Safety of radiographic imaging during pregnancy. Am Fam Physician 1999;59:1813-8.
42. Forstner R, Kalbhen CL, Filly RA, Hricak H. Abdominopelvic MR imaging in the nonobstetric evaluation of pregnant patients. AJR Am J Roentgenol 1996;166:1139-44.
43. Cappell MS. The safety and efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 1998;27:37-71.
44. Roubenoff R, Hoyt J, Petri M, Hochberg MC, Hellmann DB. Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum 1988;18:88-110.
45. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998;338:1128-37.
46. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92.
47. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977;127:264-7.
48. Kallen B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999;93:392-5.
49. Ambrosius CL, Rasmussen SN, Hansen SH, Bondesen S, Hvidberg EF. Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid. Acta Obstet Gynecol Scand 1987;66:433-5.
50. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984;6:211-6.
51. Trallori G, d'Albasio G, Bardazzi G, Bonanomi AG, Amorosi A, Del Carlo P. et al. 5-Aminosalicylic acid in pregnancy: clinical report. Ital J Gastroenterol 1994;26:75-8.
52. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998;114:23-8.
53. Colombel JF, Brabant G, Gubler MC, Locquet A, Comes MC, Dehennault M, et al. Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet 1994;344:620-1.
54. Bell CM, Habal FM. Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol 1997;92:2201-2.
55. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172:525-9.
56. Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994;84:535-8.
57. Marteau P. Safety aspects of probiotic products. Scand J Nutr 2001;45:22-24
58. Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum Dis Clin North Am 1997;23:149-67.
59. Reimers TJ, Sluss PM. 6-Mercaptopurine treatment of pregnant mice: effects on second and third generations. Science 1978;201:65-7.
60. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:443-6.
61. Saarikoski S, Seppala M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973;115:1100-6.
62. Korelitz BI. Antimetabolites in inflammatory bowel disease: long-term experience. Mt Sinai J Med 1990;57:297-304.
63. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985;92:233-9.
64. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003;124:9-17.
65. Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990;88:589-92.
66. Mason RJ, Thomson AW, Whiting PH, Gray ES, Brown PA, Catto GR, et al. Cyclosporine-induced fetotoxicity in the rat. Transplantation 1985;39:9-12.
67. Bar OB, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001;71:1051-5.
68. Pergola PE, Kancharla A, Riley DJ. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplantation 2000;71:994-7.
69. Katz JA, Lichtenstein GR, Keenan GF, Healy DE, Jacobs SJ. Outcome of pregnancy in women receiving remicade (infliximab) for the treatment of Crohn's disease or rheumatoid arthritis (abstract). Gastroenterology 2001;120(suppl 1):366.
70. Lary JM, Daniel KL, Erickson JD, Roberts HE, Moore CA. The return of thalidomide: can birth defects be prevented? Drug Saf 1999;21:161-9.
71. Einarson A, Mastroiacovo P, Arnon J, Ornoy A, Addis A, Malm H, et al. Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol 2000;14:185-7.
72. c Journées Françaises de Pharmacovigilance, 1995: PF1.
73. Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med 1993;118:366-75.
74. Ganchrow MI, Benjamin H. Inflammatory colorectal disease and pregnancy: report of a case. Dis Colon Rectum 1975;18:706-9.
75. Brandt LJ, Estabrook SG, Reinus JF. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease. Am J Gastroenterol 1995;90:1918-22.
76. Rogers RG, Katz VL. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol 1995;12:262-4.
77. Ilnyckyji A, Blanchard JF, Rawsthorne P, Bernstein CN. Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol 1999;94:3274-8.
78. Juhasz ES, Fozard B, Dozois RR, Ilstrup DM, Nelson H. Ileal pouch-anal anastomosis function following childbirth. An extended evaluation. Dis Colon Rectum 1995;38:159-65.
79. Farouk R, Pemberton JH, Wolff BG, Dozois RR, Browning S, Larson D. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg 2000;231:919-26.
80. Hill J, Clark A, Scott NA. Surgical treatment of acute manifestations of Crohn's disease during pregnancy. J R Soc Med 1997;90:64-6.
81. Teahon K, Pearson M, Levi AJ, Bjarnason I. Elemental diet in the management of Crohn's disease during pregnancy. Gut 1991;32:1079-81.
82. Badgett T, Feingold M. Total parenteral nutrition in pregnancy: case review and guidelines for calculating requirements. J Matern Fetal Med 1997;6:215-7.
83. Rigas A, Rigas B, Glassman M, Yen YY, Lan SJ, Petridou E, et al. Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhood. Ann Epidemiol 1993;3:387-92.
84. Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000;12:25-30.
85. Ost L, Wettrell G, Bjorkhem I, Rane A. Prednisolone excretion in human milk. J Pediatr 1985;106:1008-11.
86. Munoz-Flores-Thiagarajan KD, Easterling T, Davis C, Bond EF. Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol 2001;97:816-8.
87. Giamarellou H, Kolokythas E, Petrikkos G, Gazis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989;87:49S-51S.
88. Hagemann TM. Gastrointestinal medications and breastfeeding. J Hum Lact 1998;14:259-62.
89. Narendranathan M, Sandler RS, Suchindran CM, Savitz DA. Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989;11:403-6.
90. Marteau P, Cellier C. Effets indésirables de l'acide 5-aminosalicylique. Gastroenterol Clin Biol 1997;21:377-86.
91. Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut 1981;22:452-5.
92. Dejaco C, Mittermaier C, Reinisch W, Gasche C, Waldhoer T, Strohmer H, et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001;121:1048-53.
93. Korelitz BI, Rajapakse RO. Further evidence that 6-MP taken by the father with IBD provides risk of congenital anomaly to the pregnancy. Am J Gastroenterol 2001;96:252.
94. Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000;95:684-8.
95. Korelitz BI, Rajapakse RO, Zlatanic J, Baiocco PJ, Gleim GW. 6MP for fathers with 1BD at the time of conception: the value of a large clinical experience over unrelated controls. Am J Gastroenterol 2000;95:2386-7.
96. Ben Neriah Z, Ackerman Z. WAGR syndrome in a baby - the result of 6-MP treatment in a father affected by Crohn's disease? Am J Gastroenterol 2001;96:251.
97. Penn I, Makowski EL. Parenthood in kidney and liver transplant recipients. Transplant Proc 1981;13:36-9.
98. Salmela K, Kyllonen L, Holmberg C. Renal transplantation and parenthood. Transplant Proc 1992;24:1744.
99. Wagoner LE, Taylor DO, Price GD, Sr., Hagan ME, Holland C, Olsen SL, et al. Paternity by cardiac transplant recipients. Transplantation 1994;57:1337-40.
100. Lutwak-Mann C, Schmid K, Keberle H. Thalidomide in rabbit semen. Nature 1967;214:1018-20.